Belding H. Scribner Award to Honor Neil Powe

Neil R. Powe

/kidneynews/3_10_11/17a/graphic/17af1.jpg

Presented to those who have made outstanding contributions to the care of patients with renal disorders or have substantially changed the clinical practice of nephrology, the 2011 Belding H. Scribner Award will be presented to Neil R. Powe, MD, FASN, on Saturday, November 12. Dr. Powe has published a plethora of incisive studies that have explored the effectiveness of therapies in kidney disease patients, illuminated kidney disease disparities and their causes, and advanced kidney disease awareness and prevention.

Dr. Powe is the Constance B. Wofsy Distinguished Professor at the University of California, San Francisco (UCSF), chief of medicine at San Francisco General Hospital, and vice chair of medicine at UCSF. He has made fundamental contributions in more than 350 publications that have catalyzed rigorous clinical investigation in kidney disease and shaped science in outcomes and disparities research. He has also mentored a large cadre of investigators who are conducting clinical epidemiology and patient outcomes research in kidney disease at leading academic institutions.

Some of his noteworthy studies include investigations of early referral of kidney disease patients, dialysis modality effectiveness, patient-physician contact in dialysis care, conduct of rounds in dialysis units, dialysis care by type of ownership, septicemia in dialysis patients, proteinuria screening cost-effectiveness, racial differences in cardiovascular procedure use, access to transplantation, determinants of organ donation, kidney disease management in primary care, the public health burden of kidney disease, and national surveillance of chronic kidney disease.

Dr. Powe led one of the first large, prospective cohort studies of incident end stage renal disease (ESRD) patients, the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. CHOICE, with its careful characterization of 1041 patients in dialysis facilities in 18 U.S. states, has been a resource over the past 15 years for generating important answers to pressing problems in kidney disease. Dr. Powe’s body of work has had a remarkable impact on the care of patients with kidney disease, has substantially raised public consciousness of kidney disease, and has changed the clinical practice of nephrology.

Dr. Powe earned his medical degree at Harvard Medical School. He completed his residency and fellowship at the University of Pennsylvania. Prior to joining UCSF, Dr. Powe served as the James Fries University Distinguished Service Professor of Medicine and director of the Welch Center at Johns Hopkins University. He is a member of the American Society of Clinical Investigation, the Association of American Physicians, and the Institute of Medicine.

Belding H. Scribner

/kidneynews/3_10_11/17a/graphic/17af2.jpg

Belding H. Scribner, MD, developed the arteriovenous shunt, which made possible long-term hemodialysis for chronic renal failure.

Dr. Scribner served as head of the University of Washington’s Division of Nephrology in the Department of Medicine from 1958 to 1982. He and his co-workers at the Seattle university made numerous contributions to helping patients with end stage renal disease, including establishing the world’s first out-of-hospital dialysis unit, developing a home hemodialysis program, improving techniques and equipment for hemodialysis and peritoneal dialysis, and studying the adequacy and complications of chronic renal disease treated by dialysis. Dr. Scribner’s work made a significant contribution to transforming nephrology into a major subspecialty of internal medicine.


October-November 2011 (Vol. 3, Number 10 & 11)